Cedric Francois, Chief Executive Officer at Apellis Pharmaceuticals, Inc. (APLS), sold 5,686 shares at $64.14 ($365K) on 2024-01-29, disclosed to the SEC on 2024-01-31.
Seasonal sale ($365k) by Chief Executive Officer — this insider has traded APLS in January in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $64.14 | 2,843 | $182K | 50.0% |
| 2 | $64.14 | 2,843 | $182K | 50.0% |
| Total | $64.14 avg | 5,686 | $365K | 100% |
| Filing → |
| APLS | SELL | 2026-01-15 | $226K | — | Filing → |
| APLS | SELL | 2025-08-29 | $12.7M | — | Filing → |
| APLS | SELL | 2025-07-18 | $797K | — | Filing → |